| Revenue | DKK 57,5M | — |
| EBITDA | DKK -5,1M | — |
| Net profit | DKK -4,7M | — |
| Total assets | DKK 28,4M | — |
| Equity | DKK -4,6M | — |
| Employees | 2 | — |
| Item | 2019 |
|---|---|
| Revenue | 57.528 |
| Staff expenses | -6.888 |
| EBITDA | -5.116 |
| Depreciation & amort. | -0 |
| EBIT | -5.116 |
| Net financials | 0 |
| Profit before tax | -5.116 |
| Tax | -457 |
| Net profit | -4.659 |
| Item | 2019 |
|---|---|
| Total assets | 28.399 |
| Equity | -4.609 |
| Long-term debt | 146 |
| Short-term debt | 32.862 |
| Total debt | 33.007 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KP Management | Management | 2018 | — | — |
LM Management | Management | 2018 | — | — |
SH Management | Management | 2018 | — | — |
AY Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
ML Management | Management | 2018 | — | — |
ET Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
PA Management | Management | 2019 | — | — |
UK Founder | Founder | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Karo Pharma ApS | Company | 100.0% | 100.0% | 2020 |
| Individual | 100.0% | 100.0% | 2018 |
| Person | Role here | Other companies |
|---|---|---|
| Kunal Pandit | Management | 0 companies |
| Lars Magnus Nylén | Management | 0 companies |
| Sven Håkan Björklund | Management | 0 companies |
| Alex Yu | Chief Executive Officer | 0 companies |
| Mats Lennart Atterwall | Management | 0 companies |
| Esad Toric | Chief Executive Officer | 0 companies |
| Per Anders Larnholt | Management | 0 companies |
| Ulrik Kloss Fenneberg | Founder | 0 companies |
| Jon Sebastian Jonsson | Board of Directors | 0 companies |
| Christoffer Fiorini Lorenzen | Chairman | 0 companies |
| Lars Magnus Nylén | Board of Directors | 0 companies |